Etoricoxib
Etoricoxib (MK-663) is a selective COX-2 inhibitor NSAID used in research for its analgesic and anti-inflammatory properties. Studies investigate its potential antineoplastic effects, including the inhibition of tumor cell proliferation and angiogenesis, in both in vitro and in vivo models.
Product Specifications
CAS Number
202409-33-4
Product Name Alternative
MK0663, MK-0663, MK 663, MK 0663, Nucoxia, MK663, MK-663, inhibit, L 791456, Etoricoxib, L791456, L-791456, Inhibitor, Arcoxia, Desvenlafaxine, COX, Cyclooxygenase, Tauxib
Field of Research
Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery
Purity
99.68% (May vary between batches)
Solubility
DMSO:252 mg/mL (702.26 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (13.93 mM) ; Ethanol:43 mg/mL (119.83 mM)
Smiles
CC1=NC=C (C=C1) C1=NC=C (Cl) C=C1C1=CC=C (C=C1) S (C) (=O) =O
Molecular Formula
C18H15ClN2O2S
Molecular Weight
358.84
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NB300-140MFV500 0.1 mL
Mouse Monoclonal alpha-Internexin Antibody (2E3) [mFluor Violet 500 SE]
Sign In for Pricing
View Details